Introduction to clinical research - II

5,420
-1

Published on

About Clinical Research

Published in: Health & Medicine, Business
0 Comments
5 Likes
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
5,420
On Slideshare
0
From Embeds
0
Number of Embeds
5
Actions
Shares
0
Downloads
564
Comments
0
Likes
5
Embeds 0
No embeds

No notes for slide
  • clinical trial is designed to test hypotheses and rigorously monitor and assess what happens, clinical trials can be seen as the application of the scientific method, and specifically the experimental step, to understanding human or animal biology.The most commonly performed clinical trials evaluate new drugs, medical devices (like a new catheter), biologics, psychological therapies, or other interventions. Clinical trials may be required before the national regulatory authority[3] approves marketing of the drug or device, or a new dose of the drug, for use on patients.
  • Introduction to clinical research - II

    1. 1. Introduction to Clinical Research - II<br />By<br />Benhur Pradeep<br />Pradeep.ben84@gmail.com<br />www.myclinicalresearchbook.blogspot.com<br />
    2. 2. What is Clinical Research<br />A systematic observational and experimental biomedical studies performed in human subjects to test new drugs or combination of drugs or devices or biologics for its safety and therapeutic uses or new approaches to surgery or radiotherapy or procedures to improve the diagnosis of disease and the Quality life of the patient.<br />www.myclinicalresearchbook.blogspot.com<br />
    3. 3. Purpose of Research<br />Intended to increase knowledge about how well a diagnostic test or treatment works in a particular patient population.<br />To test hypothesis formulated from observations and or intuition.<br />Ultimately to understand better one’s world and make “Sense of it”.<br />www.myclinicalresearchbook.blogspot.com<br />
    4. 4. New Drug Development Process<br />Candidate Selection Point<br />Selected for Proof of Concept<br />Development Decision Point<br />Full Development Point<br />Phase III Check Point<br />Submission Decision Point<br />IND<br />NDA<br />www.myclinicalresearchbook.blogspot.com<br />
    5. 5. Ethical Norms in Clinical Research<br />3 ethical principles guide clinical research<br />www.myclinicalresearchbook.blogspot.com<br />
    6. 6. Ethical Norms of Clinical Trials<br />Sound study designs take into account:<br />Randomization or sharing of risks<br />Proper use of placebo <br />Processes to monitor safety of Rx/Tx<br />Competent investigators<br />Informed consent<br />Equitable selection of participants<br />Compensation for study related injuries<br />www.myclinicalresearchbook.blogspot.com<br />
    7. 7. Clinical Research - Phases<br />www.myclinicalresearchbook.blogspot.com<br />
    8. 8. Major players in Research team<br />Investigator<br />Clinical Research Associate<br />Clinical Research Coordinator<br />Data Manager<br />Statistician<br />Patients<br />IRB<br />Regulatory Body<br />www.myclinicalresearchbook.blogspot.com<br />
    9. 9. Principal Investigator<br />A person responsible for the conduct of the clinical trial at a trial site. If a trial is conducted by a team of individuals at a trial site, the investigator is the responsible leader of the team and may be called the principal investigator.<br />www.myclinicalresearchbook.blogspot.com<br />
    10. 10. Responsibilities : Investigator<br /><ul><li>Investigators Qualifications
    11. 11. Adequacy of Resources
    12. 12. Medical Care of Study Participants
    13. 13. Communication with the IRB / IEC
    14. 14. Compliance with the Protocol
    15. 15. Investigational Product care
    16. 16. Randomization & unbinding
    17. 17. The Informed Consent
    18. 18. Records and Reports
    19. 19. Progress Reports
    20. 20. Safety Reporting
    21. 21. Stopping or suspending a study
    22. 22. Final report by investigator</li></ul>www.myclinicalresearchbook.blogspot.com<br />
    23. 23. CRC<br />Person who handles most of the administrative responsibilities of a clinical trial, acts as liaison between investigative site and sponsor, and reviews all data and records before a monitor’s visit.<br />Functions as extension of Investigator.<br />Involved in operational duties – recruiting, scheduling, completing CRF’s, administering tests.<br />www.myclinicalresearchbook.blogspot.com<br />
    24. 24. CRA (Monitor)<br />A person appointed by the Sponsor or Contract Research Organisation (CRO) for monitoring and reporting the progress of the trial and for verification of data.<br />The monitor ensures that the trial is conducted, recorded and reported in accordance with the Protocol, Standard Operating Procedures (SOPs), Good Clinical Practice (GCP) and the applicable regulatory requirements.<br />www.myclinicalresearchbook.blogspot.com<br />
    25. 25. Responsibilities: Monitor<br />Main line of communication between sponsor and site<br />Site feasibility Training and support<br />to site staff & selection<br />Protocol & GCP Compliance<br />Document completeness & maintenance<br />Source Data Verification<br />Trial material accounting<br />Ensure timely AE & SAE reporting<br />Monitoring reports & other office documentations<br />Prepare and assist in IRB, Regulatory and internal audit or inspection<br />Assist in IRB and Regulatory Submission<br />Assist in IRB and Regulatory Submission<br />www.myclinicalresearchbook.blogspot.com<br />
    26. 26. Study Start Up<br />Site Startup<br />Study Conduct<br />Study Completion<br />www.myclinicalresearchbook.blogspot.com<br />
    27. 27. Feasibility Studies<br />Protocol feasibility: To assess from the region(s)/country(ies) where the clinical study is to be conducted, agreement on important study criteria like inclusion exclusion criteria, comparator drug, and study procedures outlined in the Protocol Synopsis, to prevent the need for protocol amendments later in the planning process<br />A secondary objective is to provide information to support finalization of the country/region allocation <br />www.myclinicalresearchbook.blogspot.com<br />
    28. 28. Feasibility Studies<br />Site feasibility: involves assessing site potential based on multivariate factors like Principal Investigators experience & interest in Clinical Research, patient inflow, accessibility to the site, availability of patients that meet the study criteria, and other related factors that affect the accrual rates and proper conduct of study related activities. <br />This is done to ensure that appropriate sites/Principal Investigators are identified<br />www.myclinicalresearchbook.blogspot.com<br />
    29. 29. Site Selection<br />It can be defined as a systematic planned process to evaluate and select an investigator and site for conduct of clinical trial <br />Factors involved in selection<br />Reputation in field<br />Facilities desirable for trial conduct<br />Access to patient population<br />Accessible geographic location<br />Anticipated time for initiation and completion of trial<br />Relationship with sponsor<br />Budgetary factors<br />Past experience<br />Experienced staff<br />EC–ability to process protocols fairly and expeditiously<br />www.myclinicalresearchbook.blogspot.com<br />
    30. 30. Investigator Meeting<br />Purpose<br />Achieve uniformity in approach by all investigators <br />Review and discuss the protocol<br />Answer questions<br />Generate enthusiasm <br />Get everyone to know each other and develop a sense of teamwork and trust<br />Review potential difficulties, issues and problems<br />Review administrative ground rules<br />www.myclinicalresearchbook.blogspot.com<br />
    31. 31. Site Initiation<br />Study initiation is done to review protocol, processes and procedures to ensure that all site personnel understand requirements of trial<br />Sites are initiated after all regulatory & ethical documentation is complete, after IP and other supplies are shipped and before any patients are enrolled <br />www.myclinicalresearchbook.blogspot.com<br />
    32. 32. Monitoring<br />Purpose<br />􀂙 To verify<br /> protection of rights and well-being of subjects<br />reported trial data is accurate, complete, and verifiable<br />trial is in compliance with:<br />Protocol and amendments<br />Regulatory requirements<br />Enrolment<br />Drug supply<br />www.myclinicalresearchbook.blogspot.com<br />
    33. 33. Study Close Out<br />After ensuring the study is complete <br />All CRF received<br />All study material is accounted for<br />All investigational product is accounted for and balance returned to sponsor<br />Ensure payment completion<br />www.myclinicalresearchbook.blogspot.com<br />
    34. 34. Key Issues<br />www.myclinicalresearchbook.blogspot.com<br />
    35. 35. Site Management<br />A structured & planned approach to manage various research activities/functions at a site to ensure execution through compliance and strict adherence to safety standards -through periodic monitoring per pre-determined/planned monitoring plan.<br />Site Management<br />www.myclinicalresearchbook.blogspot.com<br />
    36. 36. Study Documents<br />Investigator’s Boucher<br />Protocol<br />Informed Consent Form<br />Case Report Form<br />Financial Disclosure Form<br />EC Approval Letter<br />Clinical Trial Agreements and Budget<br />Lab Normal Ranges<br />Sample Labels<br />Pre trial Monitoring Report<br />Signed Agreements between 2 parties.<br />www.myclinicalresearchbook.blogspot.com<br />
    37. 37. Process Flow<br />Pre-study planning (Personnel, Other resources, EC approvals etc.,)<br />Agreements<br />Closing meeting, Evaluation of the study<br />Close the data, dispatch of the data archiving<br />Investigators meeting, practical planning, training<br />Ethics, Feasibility significance<br />Conduct of study: Recruitment of the participants, Informed consent, Clinical examinations, Specimen collection, Dispatch, Documentation<br />Data analysis Correction<br />Study Protocol<br />Central Lab<br />Proposal of study<br />Queries<br />Monitoring<br />www.myclinicalresearchbook.blogspot.com<br />
    38. 38. Thank you<br />www.myclinicalresearchbook.blogspot.com<br />

    ×